Dr. Reddy's Laboratories
RDY
#1703
Rank
ยฃ8.87 B
Marketcap
ยฃ10.61
Share price
0.07%
Change (1 day)
-4.52%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): ยฃ0.69 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are ยฃ3.95 Billion. In 2024 the company made an earning of ยฃ0.67 Billion, an increase over its 2023 earnings that were of ยฃ0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.69 B3.84%
2024 ยฃ0.67 B7.01%
2023 ยฃ0.62 B17.62%
2022 ยฃ0.53 B43.27%
2021 ยฃ0.37 B31.44%
2020 ยฃ0.28 B54.54%
2019 ยฃ0.18 B-14.21%
2018 ยฃ0.21 B26.15%
2017 ยฃ0.16 B4.69%
2016 ยฃ0.16 B-55.7%
2015 ยฃ0.36 B1.83%
2014 ยฃ0.35 B-3.78%
2013 ยฃ0.37 B54.07%
2012 ยฃ0.24 B-16.23%
2011 ยฃ0.28 B56.66%
2010 ยฃ0.18 B-235.36%
2009 -ยฃ0.14 Billion-198.53%
2008 ยฃ0.13 B30.77%
2007 ยฃ0.10 B-14.61%
2006 ยฃ0.12 B703.63%
2005 ยฃ15.45 M649.45%
2004 ยฃ2.06 M-95.68%
2003 ยฃ47.67 M-14.86%
2002 ยฃ55.99 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.89 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.32 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ6.99 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
ยฃ12.31 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ6.82 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France